deguelin has been researched along with Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Li, W; Ma, C; Wang, G; Xie, S; Xu, F; Xu, J; Xu, S; Yao, H; Zhu, Z | 1 |
| Lin, ZY; Wu, L; Yao, TZ; Yun, QZ; Zhang, TW | 1 |
| Aggarwal, D; Aggarwal, V; Bishayee, A; Kaur, G; Kumar, M; Loka, M; Masurkar, A; Mittal, S; Sak, K; Sethi, G; Tuli, HS; Varol, M | 1 |
| Bhave, AS; Goh, BC; Kumar, AP; Lam, WS; Lee, SC; Lobie, PE; Marican, AABH; Sethi, G; Syn, NL; Varughese, RS; Viganeshwari, SH; Wang, J; Wang, L; Wong, AL | 1 |
| Bilecová-Rabajdová, M; Birková, A; Durovcová, E; Gregová, K; Mareková, M; Urban, P | 1 |
| Hong, SS; Hong, WK; Jin, Q; Kim, KW; Kim, WY; Lee, HY; Myers, JN; Oh, SH; Park, HJ; Suh, YG; Woo, JK; Yazici, YD | 1 |
| Hong, WK; Jeong, JW; Jin, Q; Kang, HJ; Kim, KW; Lee, HY; Oh, SH; Woo, JK | 1 |
5 review(s) available for deguelin and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Pharmacological basis and new insights of deguelin concerning its anticancer effects.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Cycle; Humans; Neoplasm Metastasis; Neoplasms; Nucleophosmin; Rotenone | 2021 |
Deguelin targets multiple oncogenic signaling pathways to combat human malignancies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinogenesis; Cell Proliferation; Humans; Neoplasms; Rotenone; Signal Transduction | 2021 |
Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Development; Humans; Neoplasms; Rotenone | 2019 |
Naturally occurring substances and their role in chemo-protective effects.
Topics: Biological Products; Calcitriol; Estrogen Receptor Modulators; Humans; Neoplasms; Polyphenols; Protective Agents; Retinoids; Rotenone; Sulfur Compounds; Terpenes | 2013 |
3 other study(ies) available for deguelin and Neoplasms
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of truncated deguelin derivatives as Hsp90 inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Proteasome Endopeptidase Complex; Rotenone; Structure-Activity Relationship | 2019 |
Structural basis for depletion of heat shock protein 90 client proteins by deguelin.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Binding Sites; Binding, Competitive; Cell Growth Processes; Female; Fructose-Bisphosphate Aldolase; HSP90 Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Mice; Mice, Nude; Models, Molecular; Neoplasms; Reactive Oxygen Species; Rotenone; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |
Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
Topics: Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Aorta; Blotting, Western; Cell Hypoxia; Cell Movement; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Collagen; Culture Media, Conditioned; Cysteine Proteinase Inhibitors; Drug Combinations; Endothelium, Vascular; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Laminin; Leupeptins; Luciferases; Mice; Neoplasms; Neovascularization, Pathologic; Proteasome Endopeptidase Complex; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; Rotenone; Tumor Cells, Cultured; Ubiquitin; Vascular Endothelial Growth Factor A; Zebrafish | 2008 |